As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Over the last year, weight loss jabs have become highly popular, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. There has also ...

While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...

Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, ...